0. DOCID:23267 SCORE: 0.00256685937500105
DOCNO: 7658533
AUTHOR: K J Ho KJ
AFFILIATION: Department of Laboratory Medicine, National Taiwan University, College of Medicine, Taipei.
PUBTYPE: Clinical Trial
PUBTYPE: Journal Article
JOURNALTITLE: The Journal of urology.
COUNTRY: UNITED STATES
TITLE: Urinary beta-glucuronidase in screening and followup of primary urinary tract malignancy.
PUBDATE: 19951001
PURPOSE: The usefulness of urinary beta-glucuronidase in screening and followup of urinary tract malignancy was tested. MATERIALS AND METHODS: The activity and concentration of urinary beta-glucuronidase were determined in 80 healthy subjects, 113 urology patients with no cancer, and 60 with transitional cell and 23 with renal cell carcinoma. Patients with cancer were followed for 3 to 33 weeks. RESULTS: The enzyme activity and concentration were significantly greater in the cancer group, including residual tumor or recurrence after therapy, than in the controls with excellent discrimination. CONCLUSIONS: Urinary beta-glucuronidase was indeed useful in screening and followup of urinary tract malignancy.

1. DOCID:17324 SCORE: 0.00235588092909713
DOCNO: 8390708
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: radiotherapy
QUALIFIER: radiotherapy
AUTHOR: M D Isla Casado MD
AUTHOR: R Escó Barón R
AUTHOR: A Castillo Ramírez A
AFFILIATION: Servicio de Oncología Radioterápica, Hospital Clínico Universitario de Zaragoza.
PUBTYPE: Journal Article
JOURNALTITLE: Revista clínica española.
COUNTRY: SPAIN
TITLE: [Survival analysis in lung cancer treated with radiotherapy]
PUBDATE: 19930501
From June-78 to December-89, 300 patients with histologic diagnosis of non-small cell lung cancer were treated with radiotherapy by different indications: radical intention, post-chemotherapy, palliative intention, symptomatic and postsurgery. It was employed an electrons lineal accelerator principally, and for symptomatic radiotherapy treatment was used telegammatherapy by cobalt-60. It was treated an retrospective non comparative study which it has analyzed the survival of the different radiotherapy indications.

2. DOCID:23917 SCORE: 0.00225374623685073
DOCNO: 9155138
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: surgery
QUALIFIER: methods
QUALIFIER: surgery
QUALIFIER: methods
AUTHOR: M Kamiyoshihara M
AUTHOR: T Hirai T
AUTHOR: O Kawashima O
AUTHOR: Y Morishita Y
AFFILIATION: Department of Surgery, National Sanatorium Nishigunma Hospital, Gunma, Japan.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: [Zasshi] [Journal]. Nihon Kyōbu Geka Gakkai.
COUNTRY: JAPAN
TITLE: [Video-assisted thoracoscopic surgery for a 89-year-old patient with primary lung cancer--report of a case]
PUBDATE: 19970401
A 89-year-old woman was referred to our hospital because of a relatively defined shadow of the right peripheral lung in chest roentgenograms. Although this case couldn't be diagnosed with transbronchial lung biopsy, adenocarcinoma of the lung (c-T1N0M0) was suspected because of radiological findings. We planned video-assisted pulmonary partial resection of the S6 in consideration of age and general status. Her postoperative courses was uneventful with no complications. Video-assisted thoracoscopic surgery is one of the treatments for elderly patients with peripheral early stage lung cancer.

3. DOCID:23980 SCORE: 0.00225372643738775
DOCNO: 9257067
AUTHOR: J E Herndon JE
AUTHOR: S Fleishman S
AUTHOR: M P Kosty MP
AUTHOR: M R Green MR
AFFILIATION: CALGB Statistical Center, Duke University Medical Center, Durham, North Carolina 27705, USA.
PUBTYPE: Clinical Trial
PUBTYPE: Journal Article
PUBTYPE: Randomized Controlled Trial
JOURNALTITLE: Controlled clinical trials.
COUNTRY: UNITED STATES
TITLE: A longitudinal study of quality of life in advanced non-small cell lung cancer: Cancer and Leukemia Group B (CALGB) 8931.
PUBDATE: 19970801
A quality of life (QOL) endpoint supplemented standard clinical endpoints of survival, tumor response, and toxicity in a double-blind study conducted by the Cancer and Leukemia Group B (CALGB) where 291 patients with advanced non-small cell lung cancer (NSCLC) were randomly assigned to receive cisplatin/vinblastine with either hydrazine sulfate (HS) or placebo. The difficulties associated with the analysis of the longitudinal QOL data, and the contributions that the QOL endpoint made to the understanding of treatment differences, will be the focus of this paper.

4. DOCID:22799 SCORE: 0.00212433795295185
DOCNO: 8896111
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Ultrasonography, Mammary
AUTHOR: V P Jackson VP
AUTHOR: H E Reynolds HE
AUTHOR: D R Hawes DR
AFFILIATION: Department of Radiology, Indiana University School of Medicine, Indianapolis 46202, USA.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Seminars in ultrasound, CT, and MR.
COUNTRY: UNITED STATES
TITLE: Sonography of the breast.
PUBDATE: 19961001
Quality mammography remains the primary modality used to image the breast. Sonography currently is the most useful adjunctive technique to mammography, having roles in differentiating cystic from solid masses and in guiding interventional procedures. This article reviews these and other indications for breast ultrasound studies, including evaluation of palpable masses not visible in radiographically dense breasts, masses not completely evaluable with mammography, young patients especially susceptible to radiation damage, and abscesses. Ultrasound interpretation of cysts and solid masses are discussed, as are the relative disadvantages of ultrasound as a breast cancer screening tool.

5. DOCID:18863 SCORE: 0.0020582987329705
DOCNO: 1509462
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: adverse effects
QUALIFIER: adverse effects
QUALIFIER: adverse effects
AUTHOR: F Samdal F
AUTHOR: P F Amland PF
AUTHOR: K C Skolleborg KC
AUTHOR: F Abyholm F
AFFILIATION: Plastisk kirurgisk avdeling, Rikshospitalet, Oslo.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Tidsskrift for den Norske laegeforening.
COUNTRY: NORWAY
TITLE: [Are silicone breast prostheses dangerous?]
PUBDATE: 19920601
Since 1964 silicone breast prostheses have been implanted in 5 million women for breast reconstruction after cancer operations, to correct congenital deformities and for cosmetic reasons. There is no evidence in the literature of a correlation between silicone implants and breast cancer. Some authors claim that silicone implants reduce the reliability of mammography. Autoimmune diseases in patients with silicone mammary implants are reported in less than 40 cases. Most of these are localized or systemic scleroderma. An association with silicone implants has been suggested, but this suggestion has not been confirmed by scientific data.

6. DOCID:18917 SCORE: 0.00205826689370216
DOCNO: 1370615
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: genetics
QUALIFIER: microbiology
QUALIFIER: genetics
AUTHOR: M J Bussemakers MJ
AUTHOR: A van Bokhoven A
AUTHOR: J J van Groningen JJ
AUTHOR: F M Debruyne FM
AUTHOR: J A Schalken JA
AFFILIATION: Department of Urology (Urological Research Laboratory), University of Nijmegen, The Netherlands.
PUBTYPE: Journal Article
JOURNALTITLE: Biochemical and biophysical research communications.
COUNTRY: UNITED STATES
TITLE: Increased expression of retroviral sequences in progressionally advanced rat prostatic tumors.
PUBDATE: 19920101
Differential hybridization analysis revealed two cDNA clones, pBUS19 and pBUS30, to be overexpressed in progressionally advanced rat prostatic tumors. Northern blot analysis suggested the clones to be related although no homology in nucleotide sequence could be shown. Isolation and characterization of a pBUS19-related clone, pJG116, and computer-assisted database comparison showed that all three clones could be mapped within a rat-specific endogenous retrovirus. The importance of overexpression of retroviral sequences in advanced prostatic cancer remains unclear.

7. DOCID:23390 SCORE: 0.00200725949771955
DOCNO: 7603429
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: mortality
QUALIFIER: mortality
PUBTYPE: Journal Article
JOURNALTITLE: MMWR. Morbidity and mortality weekly report.
COUNTRY: UNITED STATES
TITLE: Pneumonia and influenza death rates--United States, 1979-1994.
PUBDATE: 19950701
The combined cause-of-death category pneumonia and influenza (P&I) (International Classification of Diseases, Ninth Revision, codes 480-487) ranks as the sixth leading cause of death in the United States following heart disease, cancer, stroke, unintentional injuries, and chronic obstructive pulmonary disease. Changes in the epidemiology of Streptococcus pneumoniae and other recognized respiratory pathogens, the increasing occurrence of drug-resistant microorganisms, and the detection of new respiratory pathogens have heightened awareness of the public health importance of severe respiratory infections. To characterize the epidemiology of P&I deaths in the United States, CDC further analyzed underlying and multiple cause-of-death mortality files for 1979-1994. This report summarizes the results of this analysis.

8. DOCID:23481 SCORE: 0.00200723186839025
DOCNO: 9273210
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: diagnosis
QUALIFIER: diagnosis
AUTHOR: C Brzozowski C
AUTHOR: T Krzeski T
AUTHOR: A Borówka A
AFFILIATION: Katedry i Kliniki Urologii Instytutu AM w Warszawie.
PUBTYPE: Journal Article
JOURNALTITLE: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.
COUNTRY: POLAND
TITLE: [Analysis of clinical symptoms of renal clear cell carcinoma]
PUBDATE: 19961101
An analysis of the clinical symptoms has been carried out in the group of 110 patients who underwent nephrectomy for a clear-cell carcinoma. Total hematuria (47.3% of patients) has been a predominant symptom of the tumour. Pain felt in the back has been noted in 39.1% of patients. Palpable tumour has been noted in 34.5% of patients. Such symptoms have been present simultaneously (Israel's triad) in 12.3% of patients. Tumour has been diagnosed accidentally, mainly with USG, in 37.3% of patients. It has been found that classic clinical symptoms of this cancer are nowadays less frequent than before introducing ultrasound examination.

9. DOCID:21938 SCORE: 0.00197423993343832
DOCNO: 8725706
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: therapeutic use
AUTHOR: V E Cullins VE
AFFILIATION: Department of Obstetrics and Gynecology, Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, Maryland 21224, USA.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: The Journal of reproductive medicine.
COUNTRY: UNITED STATES
TITLE: Noncontraceptive benefits and therapeutic uses of depot medroxyprogesterone acetate.
PUBDATE: 19960501
This paper reviews the noncontraceptive benefits and therapeutic uses of depot medroxyprogesterone acetate (DMPA). Relevant articles were reviewed using a computerized Medline search of the literature from 1966 to 1995. Good evidence shows that DMPA use is associated with reduced iron-deficiency anemia, protection against pelvic inflammatory disease, protection from endometrial cancer and improved hematologic parameters among users with sickle cell disease. More studies are needed to fully assess DMPA's impact on other disorders.

10. DOCID:23955 SCORE: 0.00194489380521195
DOCNO: 7675647
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: secondary
QUALIFIER: radionuclide imaging
QUALIFIER: surgery
QUALIFIER: instrumentation
QUALIFIER: analogs & derivatives
AUTHOR: S Adams S
AUTHOR: L Hovy L
AUTHOR: R P Baum RP
AUTHOR: M Adams M
AUTHOR: F D Maul FD
AUTHOR: H Kahla-Witzsch H
AUTHOR: L Zichner L
AUTHOR: D Jonas D
AUTHOR: G Hör G
AFFILIATION: Klinik und Poliklinik für Nuklearmedizin, Johann-Wolfgang-Goethe-Universität, Frankfurt am Main, FRG.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Nuklearmedizin.
COUNTRY: GERMANY
TITLE: [Intraoperative localization of metastases with a hand-held gamma probe]
PUBDATE: 19950801
A 50-y-old male patient with prostate cancer showed two suspicious lesions in bone scintigrams. They were assessed to be bone metastases by biopsy of the os ilium. After i.v. injection of 99mTc-HMDP a probe-guided localization permitted optimal surgical treatment. A bone metastasis in the os ilium was confirmed. The intraoperative detection with a hand-held gamma probe permitted accurate and complete excision of the tumour; the bone defect could thus be reduced to a minimum.

11. DOCID:19210 SCORE: 0.00190436483548414
DOCNO: 1298424
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Surgical Flaps
QUALIFIER: surgery
QUALIFIER: surgery
QUALIFIER: surgery
AUTHOR: A Kovacs A
AUTHOR: G Kiss G
AUTHOR: A Feher A
AUTHOR: A Mari A
AFFILIATION: Department of Dentistry and Maxillo-facial Surgery, Albert Szent-Györgyi Medical University, Szeged, Hungary.
PUBTYPE: Journal Article
JOURNALTITLE: The Journal of craniofacial surgery.
COUNTRY: UNITED STATES
TITLE: The radial forearm flap in intraoral reconstruction after a pull-through operation.
PUBDATE: 19921201
Free fasciocutaneous forearm flaps, based on the radial artery, were used to replace the tissue defect caused by pull-through operations for cancer of the floor of the mouth in 11 patients. There was no total or partial flap failure. The greatest advantage of the method is that restriction of the tongue movement is less when compared with the results of other methods. The thin forearm flaps are adaptable and pliable. The newly developed lower alveolar crest and the sublingual sulcus make prosthetic rehabilitation possible.

12. DOCID:22813 SCORE: 0.00184915815722428
DOCNO: 8541395
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: therapy
QUALIFIER: therapy
AUTHOR: M A Bookman MA
AFFILIATION: Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Current opinion in oncology.
COUNTRY: UNITED STATES
TITLE: Biologic therapies for gynecologic cancer.
PUBDATE: 19950901
Recent advances in gynecologic tumor biology are discussed with an emphasis on the development of biologic therapy. Emerging knowledge regarding growth factors, regulatory cytokines, and cellular receptors offers new insight regarding tumor biology and the interaction of tumors with the host peritoneal cavity and immune system. Efforts to target ovarian cancer with antibodies directed against tumor-associated antigens have begun to take advantage of molecular engineering techniques and have also explored an expanded panel of radionuclides with improved conjugation technology. It is hoped that these efforts will translate into successful strategies to improve the long-term survival of patients in conjunction with conventional chemotherapy.

13. DOCID:19756 SCORE: 0.00184709975160271
DOCNO: 7692137
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: chemistry
QUALIFIER: mortality
QUALIFIER: analysis
QUALIFIER: analysis
AUTHOR: T Shoji T
AUTHOR: T Kamiya T
AUTHOR: A Tsubura A
AUTHOR: Y Hamada Y
AUTHOR: T Hatano T
AUTHOR: K Hioki K
AUTHOR: S Morii S
AFFILIATION: Department of Pathology, Kansai Medical University, Osaka, Japan.
PUBTYPE: Journal Article
JOURNALTITLE: The Journal of surgical research.
COUNTRY: UNITED STATES
TITLE: Tenascin staining positivity and the survival of patients with invasive breast carcinoma.
PUBDATE: 19930901
Tenascin immunohistochemical staining was investigated in 82 patients with primary invasive breast carcinoma followed for at least 5 years after surgery; the staining was analyzed in relation to clinicopathological factors. An intense tenascin staining pattern was noted in 59 patients (72%), but no definite correlation was found between tenascin positivity and clinical stage, lymph node metastasis, or estrogen receptor status. However, tenascin-positive patients had a significantly better prognosis than tenascin-negative patients. Tenascin staining may therefore be a useful marker for predicting the survival of breast cancer patients.

14. DOCID:19705 SCORE: 0.00183630084954355
DOCNO: 2068635
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapy
QUALIFIER: therapy
QUALIFIER: complications
AUTHOR: P G Giri PG
AFFILIATION: Department of Radiation Oncology, University of Kansas Medical Center, Kansas City 66103.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Southern medical journal.
COUNTRY: UNITED STATES
TITLE: Cancers of the maxillary sinus.
PUBDATE: 19910701
Maxillary sinus cancers are rare as compared with cancers of other sites. Because the onset is insidious, they are at an advanced stage at diagnosis and therefore present a therapeutic challenge for local control. Traditionally, treatment has been surgery or irradiation, or a combination of the two. Local control and survival, however, remains poor. Numerous chemotherapeutic agents have shown activity against squamous cell cancers of the head and neck. In several studies the use of either neoadjuvant or concurrent chemotherapy has improved local control and survival when compared with historical controls. Randomized studies are needed to confirm the benefit of chemotherapy over the standard forms of surgical and radiation therapy.